Embecta said Tuesday that it will cancel its insulin patch pump program just months after receiving clearance from the Food and Drug Administration for its first product. The Parsippany, New ...

Embecta will cut approximately 125 jobs in Andover, Massachusetts, after announcing last week that it will discontinue its insulin patch pump program, a company spokesperson told MedTech Dive in an ...

Embecta said Tuesday that it will cancel its insulin patch pump program just months after receiving clearance from the Food and Drug Administration for its first product. The Parsippany ...

Get up to 30% off detailed market research reports-for a limited time only! The insulin patch pumps market size is expected to see rapid growth in the next few years. It will grow to $2.16 billion ...

Embecta (Nasdaq:EMBC) announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan. Shares of EMBC ticked up 4.3% to $14.41 apiece before hours after ...

3rd class company he mene last year vgo i classic liye thy 2 set same model dono kharab hogaye ghar me use ho rhe thy aam market me nii ban rhe board nii he company bheja aik month se para he abi tak ...

Despite winning an FDA green light nearly three months ago for its first wearable insulin delivery system, Embecta is now discontinuing its patch pump program as part of a broader restructuring ...

we have decided to discontinue our insulin patch pump program and initiate an organizational restructuring plan. We believe this approach will streamline operations, reduce costs and enhance our ...

3rd class company he mene last year vgo i classic liye thy 2 set same model dono kharab hogaye ghar me use ho rhe thy aam market me nii ban rhe board nii he company bheja aik month se para he abi tak ...